Business
Celldex to Participate in Upcoming Investor Conferences
HAMPTON, N.J., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that management will participate in fireside chats
About this update from Celldex Therapeutics, Inc.
[{"type":"text","content":"HAMPTON, N.J., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that management will participate in fireside chats at the following virtual investor conferences in November: Guggenheim 3rd Annual Healthcare Talks Neuro/Immunology Conference on Tuesday, November 16, 2021 at 10:20 a.m. ETJefferies London Healthcare Conference available on-demand beginning Thursday, November 18, 2021 at 3:00 a.m. ET / 8:00 a.m. GMTEvercore ISI 4th Annual HealthCONx Conference on Tuesday, November 30, 2021 at 8:25 a.m. ET Webcasts of the presentations will be available on the \"Events & Presentations\" page of the \"Investors & Media\" section of the Celldex website. Replays will be available for 30 days following the events. About Celldex Therapeutics, Inc.Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Visit www.celldex.com. Company ContactSarah CavanaughSenior Vice President, Corporate Affairs & Administration(508) [email protected] Patrick TillSenior Director, Investor Relations & Corporate Communications(484) [email protected] \nSource: Celldex Therapeutics, Inc.","length":3933,"tagName":"div"}]